Business discussion reflecting FDA pilot voucher accelerating metabolic drug reviews

REGULATORY

18 Dec 2025

FDA Pilot Voucher Signals Faster Reviews for Metabolic Drugs

A new FDA pilot voucher could shrink review timelines for select obesity and diabetes drugs, stirring optimism and debate across the secto...

Colorful 3D rendering of mitochondria used in metabolic research

INNOVATION

17 Dec 2025

The Next Obesity Bet Lies Deep Inside Cells

As GLP-1 drugs dominate obesity care, a handful of biotechs are probing mitochondria, searching for new metabolic levers inside the cell

Zealand Pharma and OTR Therapeutics logos displayed for metabolic drug partnership

PARTNERSHIPS

16 Dec 2025

Zealand Pharma Expands Metabolic Ambitions With OTR Deal

Zealand Pharma and OTR Therapeutics strike a collaboration to develop oral metabolic drugs, widening the field beyond injectables

Prolynx logo displayed in teal circle on white background

INVESTMENT

15 Dec 2025

A $70M Bet on Longer-Lasting Metabolic Drugs

Prolynx lands fresh funding and a new CEO as investors shift focus to durability and adherence in next-generation obesity therapies

Researchers reviewing biopsy data on tablet beside lab glassware and test tubes

INNOVATION

12 Dec 2025

FDA Qualifies AI Tool to Support MASH Clinical Trials

FDA qualification of an AI pathology tool could streamline MASH trials by improving consistency, hinting at broader acceptance of AI in dr...

Assorted tablets in blister packs showcasing breakthroughs in metabolic therapies.

MARKET TRENDS

11 Dec 2025

Metabolic Breakthroughs Fuel Race for Next Gen Therapies

Lilly’s data and Zealand’s Roche pact accelerate a fast-shifting field of metabolic care

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.